Faecal microbiota transplantation for first and second episode of Clostridioides difficile infection
journal contribution
posted on 2023-02-28, 17:14 authored by Joffrey van Prehn, Fidelma FitzpatrickFidelma Fitzpatrick, Ed J Kuijper, European Study Group for Clostridioides difficile, European Study Group for Host and Microbiota InteractionFaecal microbiota transplantation is an accepted treatment for multiple recurrent Clostridioides difficile infections.
History
Comments
The original article is available at https://www.thelancet.com/Published Citation
van Prehn J, Fitzpatrick F, Kuijper EJ. Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection. Lancet Gastroenterol Hepatol. 2023;8(2):109.Publication Date
February 2023External DOI
PubMed ID
36620977Department/Unit
- Beaumont Hospital
- Clinical Microbiology
Publisher
Elsevier B.V.Version
- Accepted Version (Postprint)
Usage metrics
Keywords
European Study Group for Clostridioides difficile and the European Study Group for Host and Microbiota InteractionFaecal microbiota transplantation (FMT)Clostridioides difficile infection (CDI)treatmentmultiple recurrentEncapsulated faecesvancomycinfirst episodeinflammatory bowel disease (IBD)disturbed gut microbiotaCorrespondenceBacteriologyClinical MicrobiologyInfectious Agents
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC